Rational design of a new cytarabine-based prodrug for highly efficient oral delivery of cytarabine
To overcome the drawbacks of cytarabine such as bad liposolubility and low bioavailability, we rationally designed a new cytarabine-based prodrug for oral cytarabine delivery, realizing significantly enhanced bioavailability for cancer therapy.
2012 ◽
Vol 22
(13)
◽
pp. 2830-2836
◽
Keyword(s):
Keyword(s):